Press Relations Management for the FormaRIC Platform Launch

In France, 600,000 adults with CIR (Chronic Inflammatory Rheumatism), a progressive autoimmune disease characterized by joint pain, swelling, and stiffness, navigate a complex healthcare journey. These conditions significantly impact mental health for 80% of patients and require coordinated care between primary and hospital-based medicine with prolonged multidisciplinary follow-up.
The Rhumatech Alliance and Observia, in partnership with Cochin Hospital, has launched FormaRIC, a free platform designed to optimize the management of CIR, which improves symptom monitoring, offers educational content for patients and caregivers, and facilitates the flow of information within the medical team.
Context and objectives
Yucatan supports the Rhumatech Alliance and Observia in publicizing and promoting FormaRIC, an innovative platform dedicated to improving care management for Chronic Inflammatory Rheumatism (CIR). Yucatan’s specialized healthcare and biotech communications team drives FormaRIC’s visibility among CIR patients, caregivers, and healthcare professionals (rheumatologists, physiotherapists). Through an integrated strategy combining press relations and educational communications, Yucatan positions FormaRIC as the reference tool for optimizing care pathways for the 600,000 French CIR patients.
Missions
- Manage comprehensive press relations for FormaRIC with specialized healthcare media and journalists.
- Showcase FormaRIC as an innovative care management tool for CIR among patients, caregivers, and healthcare professionals (rheumatologists, physiotherapists).
- Build platform awareness among mainstream media by highlighting its impact on quality of life for 600,000 French CIR patients.
- Write and distribute educational and informative content highlighting FormaRIC’s benefits for improved symptom monitoring and patient engagement.
- Generate optimal media coverage around strategic partnerships (Cochin Hospital, healthcare professionals) to strengthen FormaRIC’s credibility.
References









